| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.22B | -58.1% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 11.8% | Net margin -2.9% |
| Revenue Q/Q | +18.7% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.19B | 88.2% |
| SG&A | ¥0.03B | 14.3% |
| Tax & other | ¥0.00B | 0.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
瑞丰高材 ・ 迪安诊断 ・ ST天玑 ・ 宝莱特 ・ 融捷健康 ・ 新开普 ・ 依米康 ・ 初灵信息 ・ 金信诺 ・ 卫宁健康 ・ 仟源医药 ・ 常山药业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies